These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Maximizing function in Alzheimer's disease: what role for tacrine? Smucker WD Am Fam Physician; 1996 Aug; 54(2):645-52. PubMed ID: 8701842 [TBL] [Abstract][Full Text] [Related]
3. Tacrine therapy for the dementia of Alzheimer's disease. Manning FC Am Fam Physician; 1994 Sep; 50(4):819-26. PubMed ID: 8079912 [TBL] [Abstract][Full Text] [Related]
4. [Tacrine in Alzheimer's disease]. López de Munain A Rev Neurol; 1997 Jul; 25 Suppl 1():S70-2. PubMed ID: 9280671 [No Abstract] [Full Text] [Related]
5. Advances in the treatment of Alzheimer's disease. Schneider LS Aging (Milano); 1998 Apr; 10(2):156-7. PubMed ID: 9666210 [No Abstract] [Full Text] [Related]
6. [Treatment of Alzheimer's disease]. Soininen H Duodecim; 1997; 113(18):1739-46. PubMed ID: 10892065 [No Abstract] [Full Text] [Related]
7. Tacrine. Alzheimer's disease and the cholinergic theory. A critical review and results of a new therapy. Boller F; Orgogozo JM Neurologia; 1995 May; 10(5):194-9. PubMed ID: 7619536 [No Abstract] [Full Text] [Related]
8. A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group. Davis KL; Thal LJ; Gamzu ER; Davis CS; Woolson RF; Gracon SI; Drachman DA; Schneider LS; Whitehouse PJ; Hoover TM N Engl J Med; 1992 Oct; 327(18):1253-9. PubMed ID: 1406817 [TBL] [Abstract][Full Text] [Related]
9. Tacrine for Alzheimer's disease. Med Lett Drugs Ther; 1993 Sep; 35(905):87-8. PubMed ID: 8361451 [No Abstract] [Full Text] [Related]
10. Tacrine in relation to amino acid transmitters in Alzheimer's disease. Bowen DM; Steele JE; Lowe SL; Palmer AM Adv Neurol; 1990; 51():91-6. PubMed ID: 1967197 [No Abstract] [Full Text] [Related]
13. [Effects of amiridin and tacrine, drugs effective in Alzheimer's disease, on synaptosomal uptake of neuromediators]. Burov IuV; Baĭmanov TD; Maĭsov NI Biull Eksp Biol Med; 1992 Apr; 113(4):379-81. PubMed ID: 1356507 [TBL] [Abstract][Full Text] [Related]
14. Tacrine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in Alzheimer's disease. Wagstaff AJ; McTavish D Drugs Aging; 1994 Jun; 4(6):510-40. PubMed ID: 7521234 [TBL] [Abstract][Full Text] [Related]
15. Tacrine and lecithin in Alzheimer's disease. Tacrine is safe and effective. Pendlebury WW; Solomon PR BMJ; 1994 Jun; 308(6942):1506; author reply 1507. PubMed ID: 8019290 [No Abstract] [Full Text] [Related]
16. Do blood pressure and age predict response to tacrine (THA) in Alzheimer's disease? A preliminary report. Schneider LS; Lyness SA; Pawluczyk S; Gleason RP; Sloane RB Psychopharmacol Bull; 1991; 27(3):309-14. PubMed ID: 1775604 [TBL] [Abstract][Full Text] [Related]
17. [Tacrine in the treatment of Alzheimer's disease]. Weinstein HC; Teunisse S; van Gool WA; van Crevel H Ned Tijdschr Geneeskd; 1991 Aug; 135(35):1575-7. PubMed ID: 1922487 [No Abstract] [Full Text] [Related]
18. Tacrine in Alzheimer's disease. Lachs M N Engl J Med; 1993 Mar; 328(11):809-10. PubMed ID: 8437606 [No Abstract] [Full Text] [Related]
19. Effect of tacrine in Alzheimer's disease: or non-effect? Broe GA; Creasey H Med J Aust; 1994 Sep; 161(6):348-9. PubMed ID: 8090107 [No Abstract] [Full Text] [Related]